← Leaderboards
Toshiaki Maruyama
Abwiz Bio, Inc.
$555,185
Attributed
$1,110,369
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,110,369 · 3
By mechanism
R41$1,110,369 · 3
Top collaborators
- Shiva Shahrara2 shared
- Toshiaki Kawakami1 shared
- Erica Ollmann Saphire1 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsAffinityBindingSafety StudyAntigensReceptorEpitopesMouse ModelMolecular ConformationEngineeringAntibodiesLibrariesBaseEnzyme-Linked Immunosorbent AssayAffectAntibody LibrariesPhage DisplayBoneBlood CellsBone ErosionAgonistAnti-Tumor Necrosis Factor TherapyAlternative Treatment
Grant awards (4)
Development of Neutralizing Antibodies to Machupo Virus$280,769
R41 · FY2024 · AI · contact PI
Engineering a unique antibody for patients with RA$300,000
R41 · FY2021 · AI · contact PI
Engineering a unique antibody for patients with RA$300,000
R41 · FY2020 · AI · contact PI
Blockade of histamine-releasing factor as a new prophylactic and therapeutic strategy for food allergy$229,600
R41 · FY2016 · AI · contact PI